Title |
Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy
|
---|---|
Published in |
OncoTargets and therapy, July 2021
|
DOI | 10.2147/ott.s312904 |
Pubmed ID | |
Authors |
Haibo Zhu, Haobin Deng, Juan Mu, Cuicui Lyu, Yanyu Jiang, Qi Deng |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 11% |
United States | 1 | 11% |
France | 1 | 11% |
Unknown | 6 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 78% |
Scientists | 2 | 22% |
Mendeley readers
The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 24 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 3 | 13% |
Other | 2 | 8% |
Student > Ph. D. Student | 2 | 8% |
Lecturer | 1 | 4% |
Student > Doctoral Student | 1 | 4% |
Other | 3 | 13% |
Unknown | 12 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 25% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 13% |
Nursing and Health Professions | 1 | 4% |
Immunology and Microbiology | 1 | 4% |
Agricultural and Biological Sciences | 1 | 4% |
Other | 2 | 8% |
Unknown | 10 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2023.
All research outputs
#6,733,789
of 25,872,466 outputs
Outputs from OncoTargets and therapy
#327
of 3,017 outputs
Outputs of similar age
#133,592
of 456,741 outputs
Outputs of similar age from OncoTargets and therapy
#8
of 77 outputs
Altmetric has tracked 25,872,466 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 3,017 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,741 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.